Serum Institute of India seeks DCGI's approval for market authorisation of its COVID-19 vaccine Covovax as booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin: Official sources— Press Trust of India (@PTI_News) December 22, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


